Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer von Shaw, Alice T, Ou, Sai-Hong I, Bang, Yung-Jue, Camidge, D. Ross, Solomon, Benjamin J, Salgia, Ravi, Riely, Gregory J, Varella-Garcia, Marileila, Shapiro, Geoffrey I, Costa, Daniel B, Doebele, Robert C, Le, Long Phi, Zheng, Zongli, Tan, Weiwei, Stephenson, Patricia, Shreeve, S. Martin, Tye, Lesley M, Christensen, James G, Wilner, Keith D, Clark, Jeffrey W, Iafrate, A. John

Volltext

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer von Gadgeel, Shirish M, Shaw, Alice T, Govindan, Ramaswamy, Gandhi, Leena, Socinski, Mark A, Camidge, D Ross, De Petris, Luigi, Kim, Dong-Wan, Chiappori, Alberto, Moro-Sibilot, Denis L, Duruisseaux, Michael, Crino, Lucio, De Pas, Tommaso, Dansin, Eric, Tessmer, Antje, Yang, James Chih-Hsin, Han, Ji-Youn, Bordogna, Walter, Golding, Sophie, Zeaiter, Ali, Ou, Sai-Hong Ignatius

Volltext

hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing von Goehe, Rachel Wilson, Shultz, Jacqueline C, Murudkar, Charuta, Usanovic, Sanja, Lamour, Nadia F, Massey, Davis H, Zhang, Lian, Camidge, D Ross, Shay, Jerry W, Minna, John D, Chalfant, Charles E

Volltext

EPH49 Prevalence and Incidence of ROS1 and NTRK Rearrangements in Real-World Patients With Advanced Non–Small Lung Cancer in the United States von Ma, X, Lu, Y, Lee, A, Cho-Phan, C., Su, IH, Zhang, Y, Camidge, DR, Penrod, JR, Yuan, Y

Volltext

Lorlatinib Salvages CNS Relapse in an ALK-Positive Non–Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib von Sakamoto, Mandy R., Honce, Justin M., Lindquist, Deborah L., Camidge, D. Ross

Volltext

Brigatinib versus crizotinib in advanced ALK inhibitor-naive ALK-positive non-small cell lung cancer: second interim analysis of the Phase III ALTA-1L trial von Camidge, DR, Kim, HR, Ahn, M-J, Yang, JCH, Han, J-Y, Hochmair, MJ, Lee, KH, Delmonte, A, Garcia Campelo, MR, Kim, D-W, Griesinger, F, Felip, E, Califano, R, Spira, A, Gettinger, SN, Tiseo, M, Lin, HM, Gupta, N, Hanley, MJ, Ni, Q, Zhang, P, Popat, S

Volltext

PRM157 - THE IMPACT OF LANDMARK RESPONSE ON OVERALL SURVIVAL: IMPLICATIONS FOR THE ECONOMIC EVALUATION OF IMMUNE-THERAPY (I-O) TREATMENT IN SMALL CELL LUNG CANCER (SCLC) von Santi, I, Smare, C, Juarez-Garcia, A., Camidge, DR, Schoenherr, N, Penrod, JR, Abraham, P, Korytowsky, B, Yuan, Y

Volltext

Abstract P6-17-06: Characterization, monitoring and management of interstitial lung disease in patients with metastatic breast cancer: Analysis of data available from multiple stud... von Powell, CA, Camidge, DR, Gemma, A, Kusumoto, M, Baba, T, Kuwano, K, Bankier, A, Kiura, K, Tamura, K, Modi, S, Tsurutani, J, Doi, T, Iwata, H, Krop, IE, Zhang, L, Jasmeet, S, Saito, K, Shahidi, J, Yver, A, Takahashi, S

Volltext

Genetic Susceptibility to Tuberculosis in Africans: A Genome-Wide Scan von Bellamy, Richard, Beyers, Nulda, Keith P. W. J. Mc Adam, Ruwende, Cyril, Gie, Robert, Samaai, Priscilla, Bester, Danite, Meyer, Mandy, Corrah, Tumani, Collin, Matthew, Camidge, D. Ross, Wilkinson, David, Helden, Eileen Hoal-Van, Whittle, Hilton C., Amos, William, van Helden, Paul, Adrian V. S. Hill

Volltext

Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study von Camidge, D Ross, Dr, Bang, Yung-Jue, Prof, Kwak, Eunice L, MD, Iafrate, A John, MD, Varella-Garcia, Marileila, Prof, Fox, Stephen B, Prof, Riely, Gregory J, MD, Solomon, Benjamin, MBBS, Ou, Sai-Hong I, MD, Kim, Dong-Wan, Prof, Salgia, Ravi, Prof, Fidias, Panagiotis, MD, Engelman, Jeffrey A, MD, Gandhi, Leena, MD, Jänne, Pasi A, MD, Costa, Daniel B, MD, Shapiro, Geoffrey I, MD, LoRusso, Patricia, DO, Ruffner, Katherine, MD, Stephenson, Patricia, ScD, Tang, Yiyun, PhD, Wilner, Keith, PhD, Clark, Jeffrey W, MD, Shaw, Alice T, MD

Volltext

The epidemiology of self‐poisoning in the UK von Camidge, D. R., Wood, R. J., Bateman, D. N.

Volltext

Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer von Camidge, DR, Kim, HR, Ahn, M-J, Yang, JC-H, Han, J-Y, Lee, J-S, Hochmair, MJ, Li, JY-C, Chang, G-C, Lee, KH, Gridelli, C, Delmonte, A, Garcia Campelo, R, Kim, D-W, Bearz, A, Griesinger, F, Morabito, A, Felip, E, Califano, R, Ghosh, S, Spira, A, Gettinger, SN, Tiseo, M, Gupta, N, Haney, J, Kerstein, D, Popat, S

Volltext

Targeted manipulation of apoptosis in cancer treatment von Call, Justin A, MD, Eckhardt, S Gail, Prof, Camidge, D Ross, Dr

Volltext

The Causes of Dysphagia in Carcinoma of the Lung von Camidge, D R

Volltext

Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies von Camidge, D R, Randall, K R, Foster, J R, Sadler, C J, Wright, J A, Soames, A R, Laud, P J, Smith, P D, Hughes, A M

Volltext

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development von Camidge, D R, Pemberton, M N, Growcott, J W, Johnstone, D, Laud, P J, Foster, J R, Randall, K J, Hughes, A M

Volltext

Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug... von CAMIDGE, D. R, DAVIES, M. J, LAUD, P. J, MARSHALL, A. L, COCKERILL, M, SMITH, P. D, HUGHES, A. M

Volltext

Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence von Camidge, D R, Kunkler, I H

Volltext

Brachial plexopathy affecting the development of Beau's lines unilaterally von Camidge, DR, Cameron, DA

Volltext

Cutaneous B cell lymphoma arising from a chronically inflamed sebaceous cyst von Camidge, D R, Matheson, L M

Volltext